The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
FGF-21 as a novel metabolic regulator
Open accessAbstract
Diabetes mellitus is a major health concern, affecting more than 5% of the population. Here we describe a potential novel therapeutic agent for this disease, FGF-21, which was discovered to be a potent regulator of glucose uptake in mouse 3T3-L1 and primary human adipocytes. FGF-21-transgenic mice were viable and resistant to diet-induced obesity. Therapeutic administration of FGF-21 reduced plasma glucose and triglycerides to near normal levels in both ob/ob and db/db mice. These effects persisted for at least 24 hours following the cessation of FGF-21 administration. Importantly, FGF-21 did not induce mitogenicity, hypoglycemia, or weight gain at any dose tested in diabetic or healthy animals or when overexpressed in transgenic mice. Thus, we conclude that FGF-21, which we have identified as a novel metabolic factor, exhibits the therapeutic characteristics necessary for an effective treatment of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, FGF21 stimulates the uptake of glucose by adipocytes and inhibits the production of glucose in the liver.”
From Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases (2018) · cites this paper as Kharitonenkov et al., 2005
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“FGF21 acts in the control of glucose and lipid homeostasis (Kharitonenkov et al., 2005).”
From Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases (2018) · cites this paper as Kharitonenkov et al., 2005
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, FGF21 appears to protect pancreatic β cells from cell death induced by glycotoxicity (Kharitonenkov et al., 2005, 2007).”
From Physical Exercise-Induced Myokines and Muscle-Adipose Tissue Crosstalk: A Review of Current Knowledge and the Implications for Health and Metabolic Diseases (2018) · cites this paper as Kharitonenkov et al., 2005
Experimental — accuracy not yet measuredIn the citing paper
“Interestingly, mice that overexpress FGF-21, a circulating FGF which is induced by a ketogenic diet 106, are lean and have increased brown fat 107, suggesting that the beneficial metabolic effects induced by a ketogenic diet are brought about in part by increases in BAT mass.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [107]
In the citing paper
“FGF21 binding promotes the formation of a dimeric FGFR1c–KLB signalling complex, which activates the intracellular tyrosine kinase domains of FGFR1c and propagates signalling through phosphorylation by the kinase ERK46,53,58,59”
From Metabolic messengers: FGF21 (2021) · cites this paper as [58]
In the citing paper
“prolonged administration of FGF21 or FGF21 analogues has important metabolic effects, including a marked decrease in body weight in rodents and non-human primates, and more modest effects on body weight in humans3,40,58,77,78.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [58]
In the citing paper
“overexpression of FGF21 is highly protective [135].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [135]
In the citing paper
“activation of the FGF21/FGFR1c/KLB receptor complex results in the phosphorylation of ERK1/2 and FRS2α [135].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [135]
In the citing paper
“A myriad of studies ensued demonstrating that administering FGF21 to obese or diabetic rodents and primates markedly reduced body weight and significantly improved carbohydrate and lipid homeostasis (21, 64, 65, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [64]
In the citing paper
“In rodents, pharmacological levels of FGF21 increase energy expenditure (64, 141), which results in increased food intake (54, 64).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [64]
In the citing paper
“Since FGF21 administration increases energy expenditure and the browning of adipose tissues in vivo (21, 64, 141), it was hypothesized that FGF21 regulates adaptive thermogenesis in response to cold.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [64]
In the citing paper
“When administered to diabetic and obese animal models, FGF21 provides multiple metabolic benefits and has been shown to decrease blood glucose levels and body weight, improve insulin and leptin sensitivity, improve plasma lipid profiles, and decrease hepatic steatosis (21, 64, 141, 142).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [64]
In the citing paper
“Importantly, in animal models FGF21 treatment not only prevents (64) but also reverses diabetes and obesity (21, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [64]
In the citing paper
“In addition, FGF21 enhances insulin sensitivity in primary brown adipocytes (86) but not in primary white adipocytes (64, 86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [64]
In the citing paper
“FGF21’s ability to reduce body weight, glucose levels, and lipid concentrations in models of obesity generated substantial initial interest”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [114]
In the citing paper
“Fibroblast growth factor 21 (FGF21) was first identified as an hepatokine 61 and has been shown to be necessary for the adaptation to fasting 62, 63.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 1,985
Frederich, R. C., Hamann, A., Anderson, S., Löllmann, B., Lowell, B. B., & Flier, J. S. (1995) · Nature Medicine · doi:10.1038/nm1295-1311 · Cited by 1,660
Fibroblast growth factors, their receptors and signaling
Powers, C. J., McLeskey, S. W., & Wellstein, A. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070165 · Cited by 1,332
Glucose Transporters and Insulin Action — Implications for Insulin Resistance and Diabetes Mellitus
Shepherd, P. R., & Kahn, B. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410406 · Cited by 1,295
SIGNALLING BY RECEPTOR TYROSINE KINASES
Fantl, W. J., Johnson, D. E., & Williams, L. T. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.62.1.453 · Cited by 1,118
Cheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,012
Research works printed but not linked: 3
- Konishi, 1999, J. Biol. Chem., 255, 12119
- Shah, 2000, J. Clin. Endocrinol. Metab., 85, 4053
- Cheatham, 1994, Mol. Cell. Biol., 14, 4902, 10.1128/MCB.14.7.4902 · DOI
Cited by
Sorted by citations
Items 801–900 of 1,008
Liu, M., Pan, Q., Chen, Y., Yang, X., Zhao, B., Jia, L., Zhu, Y., Zhang, B., Gao, X., Li, X., et al. (2015) · Scientific Reports · doi:10.1038/srep11219 · Cited by 45
Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease
Kralisch, S., & Faßhauer, M. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328346a326 · Cited by 44
Xu, X., Krumm, C. S., So, J., Bare, C. J., Holman, C. D., Gromada, J., Cohen, D. E., & Lee, A. (2018) · Hepatology · doi:10.1002/hep.30060 · Cited by 43
The influence of skeletal muscle on appetite regulation
Grannell, A., VITO, G. D., Murphy, J. C., & le Roux, C. W. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1618185 · Cited by 46
YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity
Wang, L., Mazagova, M., Pan, C., Yang, S. T., Brandl, K., Liu, J., Reilly, S. M., Wang, Y., Miao, Z., Loomba, R. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904360116 · Cited by 43
Forney, L. A., Fang, H., Sims, L. C., Stone, K. P., Vincik, L. Y., Vick, A. M., Gibson, A. N., Burk, D. H., & Gettys, T. W. (2020) · Obesity · doi:10.1002/oby.22919 · Cited by 43
Serum fibroblast growth factor 21 levels in polycystic ovary syndrome
Görar, S., Çulha, C., Üç, Z. A., Dellal, F. D., Serter, R., Aral, S., & Aral, Y. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487587 · Cited by 43
Toloza, F. J. K., Mantilla-Rivas, J. O., Pérez-Matos, M. C., Ricardo-Silgado, M. L., Morales-Alvarez, M. C., Pinzón-Cortés, J. A., Pérez-Mayorga, M., Arévalo-Garcia, M. L., Tolosa-González, G., & Mendivil, C. O. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00005 · Cited by 42
“Fibroblast-derived growth factor 21 levels correlated positively with percent LBM, in accordance with its action as a promoter of thermogenesis and “browning” of adipose tissue in animal models (30).”
BackgroundPorflitt-Rodríguez, M., Guzmán-Arriagada, V., Sandoval-Valderrama, R., Tam, C. S., Pavicic, F., Ehrenfeld, P., & Martínez-Huenchullán, S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155137 · Cited by 42
Zamboni, M. M., Mazzali, G., Brunelli, A., Saatchi, T., Urbani, S., Giani, A., Rossi, A. P., Zoico, E., & Fantin, F. (2022) · Cells · doi:10.3390/cells11213361 · Cited by 47
Fritsche, K., Ziková, A., Marx‐Stoelting, P., & Braeuning, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032686 · Cited by 42
Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes
Reinehr, T., Karges, B., Meißner, T., Wiegand, S., Fritsch, M., Holl, R. W., & Woelfle, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2192 · Cited by 42
Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR)
Cheng, X., Vispute, S. G., Liu, J., Cheng, C., Kharitonenkov, A., & Klaassen, C. D. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.013 · Cited by 42
Benetti, E., Mastrocola, R., Rogazzo, M., Chiazza, F., Aragno, M., Fantozzi, R., Collino, M., & Minetto, M. A. (2013) · Mediators of Inflammation · doi:10.1155/2013/509502 · Cited by 44
Zhang, J., & Li, Y. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.007 · Cited by 44
Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes
Donate‐Correa, J., Martín‐Núñez, E., Pérez‐Delgado, N., de Fuentes, M. M., Ortíz, A., Fernández, C. M., & Navarro‐González, J. F. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.12.003 · Cited by 44
Heme-Regulated eIF2α Kinase Modulates Hepatic FGF21 and Is Activated by PPARβ/δ Deficiency
Zarei, M., Barroso, E., Leiva, R., Barniol‐Xicota, M., Pujol, E., Escolano, C., Vázquez, S., Palomer, X., Pardo, V., González‐Rodríguez, Á., et al. (2016) · Diabetes · doi:10.2337/db16-0155 · Cited by 42
Curcumin and dietary polyphenol research: beyond drug discovery
Jin, T. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.179 · Cited by 43
Li, Z., Lin, M., Liu, C., Wang, D., Shi, X., Zheng, C., Liu, Y., Yang, S., & Li, X. (2018) · Cytokine · doi:10.1016/j.cyto.2018.03.023 · Cited by 45
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
Agrawal, A., Parlee, S. D., Pérez–Tilve, D., Li, P., Pan, J. H., Mroz, P. A., Hansen, A. M. K., Andersen, B., Finan, B., Kharitonenkov, A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.003 · Cited by 42
Torre-Villalvazo, I., Alemán, G., Valle‐Rios, R., & Noriega, L. G. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.06.006 · Cited by 45
Figarska, S. M., Rigdon, J., Ganna, A., Elmståhl, S., Lind, L., Gardner, C. D., & Ingelsson, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-64636-7 · Cited by 41
Hassan, F., Nadeem, A., Li, Z., Javed, M., Liu, Q., Azhar, J., Rehman, M. S.-U., Cui, K., & Rehman, S. U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212463 · Cited by 42
Endocrine fibroblast growth factors as regulators of metabolic homeostasis
Kurosu, H., & Kuro‐o, M. (2009) · BioFactors · doi:10.1002/biof.12 · Cited by 41
Cellular and Molecular Regulation of Exercise—A Neuronal Perspective
Reddy, I., Yadav, Y., & Dey, C. S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01272-x · Cited by 46
Short-Term Curcumin Gavage Sensitizes Insulin Signaling in Dexamethasone-Treated C57BL/6 Mice
Tian, L., Zeng, K., Shao, W., Yang, B. B., Fantus, I. G., Weng, J., & Jin, T. (2015) · Journal of Nutrition · doi:10.3945/jn.115.216853 · Cited by 41
“Browning” of adipose tissue – regulation and therapeutic perspectives
Peschechera, A., & Eckel, J. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.796995 · Cited by 42
FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity
Ye, M., Lu, W., Wang, X., Wang, C., Abbruzzese, J. L., Liang, G., Li, X., & Luo, Y. (2016) · Endocrinology · doi:10.1210/en.2016-1710 · Cited by 41
B'Chir, W., Dufour, C. R., Ouellet, C., Yan, M., Tam, I. S., Andrzejewski, S., Xia, H., Nabata, K. J., St‐Pierre, J., & Giguère, V. (2018) · Endocrinology · doi:10.1210/en.2018-00115 · Cited by 40
Fibroblast growth factor 9 (FGF9) inhibits myogenic differentiation of C2C12 and human muscle cells
Huang, J. M., Wang, K., Shiflett, L. A., Brotto, L. S., Bonewald, L. F., Wacker, M., Dallas, S. L., & Brotto, M. A. P. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1691796 · Cited by 44
Tong, X., Zhang, D., Buelow, K. L., Guha, A., Arthurs, B., Brady, H. J. M., & Yin, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433482 · Cited by 43
Jung, C. H., Lee, W. J., Hwang, J., Yu, J. H., Shin, M. S., Lee, M. J., Jang, J. E., Leem, J., Park, J. Y., & Kim, H. ‐. (2012) · Diabetic Medicine · doi:10.1111/dme.12104 · Cited by 41
Domouzoglou, E. M., Fisher, F. M., Astapova, I. I., Fox, E. C., Kharitonenkov, A., Flier, J. S., Hollenberg, A. N., & Maratos–Flier, E. (2014) · Endocrinology · doi:10.1210/en.2013-1902 · Cited by 41
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia
Stepan, H., Kley, K., Hindricks, J., Kralisch, S., Jank, A., Schaarschmidt, W., Schrey-Petersen, S., Ebert, T., Lössner, U., Kratzsch, J., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.02.019 · Cited by 40
Taniguchi, H., Tanisawa, K., Sun, X., Cao, Z., Oshima, S., Ise, R., Sakamoto, S., & Higuchi, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1877 · Cited by 40
Fibroblast growth factor 21 in chronic kidney disease
Anuwatmatee, S., Tang, S., Wu, B. J., Rye, K., & Ong, K. L. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.11.002 · Cited by 40
Inflammatory and Oxidative Stress Markers in Skeletal Muscle of Obese Subjects
Catalán, V., Frühbeck, G., & Gómez‐Ambrosi, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00008-8 · Cited by 44
Serum Fibroblast Growth Factor 21 Levels Are Correlated with the Severity of Diabetic Retinopathy
Lin, Y., Xiao, Y.-C., Zhu, H., Xu, Q.-Y., Qi, L., Wang, Y., Li, X., Zheng, M.-L., Zhong, R.-S., Zhang, Y., et al. (2014) · Journal of Diabetes Research · doi:10.1155/2014/929756 · Cited by 40
Bartesaghi, S., Wallenius, K., Hovdal, D., Liljeblad, M., Wallin, S., Dekker, N., Barlind, L., Davies, N. M., Seeliger, F., Winzell, M. S., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.010 · Cited by 40
FGF19 increases mitochondrial biogenesis and fusion in chondrocytes via the AMPKα-p38/MAPK pathway
Kan, S., Pi, C., Zhang, L., Guo, D., Niu, Z., Liu, Y., Duan, M., Pu, X., Bai, M., Zhou, C., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01069-5 · Cited by 41
Adipokines in atherosclerosis: unraveling complex roles
Luo, J., He, Z., Li, Q., Lv, M., Cai, Y., Ke, W., Niu, X., & Zhang, Z. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1235953 · Cited by 44
Exercise ameliorates the FGF21–adiponectin axis impairment in diet-induced obese mice
Yang, W., Liu, L., Wei, Y., Fang, C., Zhou, F., Chen, J., Han, Q., Huang, M., Tan, X., Liu, Q., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0034 · Cited by 39
Exploring the In Vivo Role of the Mitochondrial Calcium Uniporter in Brown Fat Bioenergetics
Flicker, D., Sancak, Y., Mick, E., Goldberger, O., & Mootha, V. K. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.013 · Cited by 42
FGF21 and Chronic Kidney Disease.
Salgado, J., Goes, M. A., & Salgado, N. (2021) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2021.154738 · Cited by 35
Beta-klotho in type 2 diabetes mellitus: From pathophysiology to therapeutic strategies
Hua, S., Liu, Q., Li, J., Fan, M., Yan, K., & Ye, D. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09661-1 · Cited by 39
Claflin, K. E., Sullivan, A. I., Naber, M. C., Flippo, K. H., Morgan, D. A., Neff, T. J., Jensen-Cody, S. O., Zhu, Z., Zingman, L. V., Rahmouni, K., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101564 · Cited by 37
Patel, S., Haider, A., Álvarez-Guaita, A., Bidault, G., Moustafa, J. S. E.-S., Guiu‐Jurado, E., Tadross, J. A., Warner, J., Harrison, J., Virtue, S., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101589 · Cited by 42
Staudinger, J. L., & Lichti-Kaiser, K. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700098c · Cited by 39
Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats
Aslanidi, G., Kroutov, V., Philipsberg, G. A., Lamb, K. E., Campbell‐Thompson, M., Walter, G. A., Kurenov, S. N., Aguirre, J. I., Keller, P., Hankenson, K. D., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00248.2007 · Cited by 39
Fibroblast growth factor 21 has no direct role in regulating fertility in female mice
Singhal, G., Douris, N., Fish, A. J., Zhang, X., Adams, A. C., Flier, J. S., Pissios, P., & Maratos-Flier, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.010 · Cited by 38
Liver Brain Interactions: Focus on FGF21 a Systematic Review
Prida, E., Álvarez-Delgado, S., Pérez-Lois, R., Soto-Tielas, M., Estany‐Gestal, A., Fernø, J., Seoane, L. M., Quiñones, M., & Al–Massadi, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113318 · Cited by 40
Cui, X., Feng, J. B., Wei, T., Zhang, L., Lang, S., Yang, K., Yang, J., Liu, J., Sterr, M., Lickert, H., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05822-2 · Cited by 39
Camacho, R. C., Zafian, P., Achanfuo-Yeboah, J., Manibusan, A., & Berger, J. P. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.023 · Cited by 38
Yamazaki, M., Kawai, M., Miyagawa, K., Ohata, Y., Tachikawa, K., Kinoshita, S., Nishino, J., Ozono, K., & Michigami, T. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-014-0598-2 · Cited by 38
Lee, D. V., Li, D., Yan, Q., Zhu, Y., Goodwin, B. J., Calle, R. A., Brenner, M. B., & Talukdar, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111767 · Cited by 38
Charoenphandhu, N., Suntornsaratoon, P., Krishnamra, N., Sa‐nguanmoo, P., Tanajak, P., Wang, X., Liang, G., Li, X., Jiang, C., Chattipakorn, N., et al. (2016) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-016-0745-z · Cited by 38
Libby, A. E., Bales, E. S., Monks, J., Orlicky, D. J., & McManaman, J. L. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m086249 · Cited by 38
Wang, N., Zhao, T., Li, S., Sun, X., Li, Z., Li, Y., Li, D., & Wang, W. (2019) · Obesity · doi:10.1002/oby.22376 · Cited by 38
Sasaki, Y., Raza-Iqbal, S., Tanaka, T., Murakami, K., Anai, M., Osawa, T., Matsumura, Y., Sakai, J., & Kodama, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225682 · Cited by 40
Fève, B., Bastard, C., Fellahi, S., Bastard, J., & Capeau, J. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.01.001 · Cited by 38
Larsson, S. C., Michaëlsson, K., Mola-Caminal, M., Höijer, J., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155329 · Cited by 39
Lundåsen, T., Andersson, E.-M., Snaith, M. R., Lindmark, H., Lundberg, J., Östlund‐Lindqvist, A., Angelin, B., & Rudling, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037787 · Cited by 38
Protein metabolism and related body function: mechanistic approaches and health consequences
Tomé, D., Benoit, S., & Azzout‐Marniche, D. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120007880 · Cited by 39
Brown, E. A., Minnich, A., Sanyal, A. J., Loomba, R. S., Du, S., Schwarz, J., Ehman, R. L., Karsdal, M. A., Leeming, D. J., Cizza, G., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2022.100661 · Cited by 37
Fibroblast growth factor 21 in metabolic syndrome
Yang, M., Liu, C., Jiang, N., Liu, Y., Luo, S., Li, C., Zhao, H., Han, Y., Chen, W., Li, L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1220426 · Cited by 40
Abrosimov, R., Baeken, M. W., Hauf, S., Wittig, I., Hajieva, P., Perrone, C. E., & Moosmann, B. (2024) · GeroScience · doi:10.1007/s11357-023-01059-y · Cited by 37
Jin, Q., Bando, Y., Miyawaki, K., Shikama, Y., Kosugi, C., Aki, N., Funaki, M., & Noji, S. (2014) · The Journal of Medical Investigation · doi:10.2152/jmi.61.28 · Cited by 37
Luo, Y., Yang, C., Ye, M., Jin, C., Abbruzzese, J. L., Lee, M., Yeung, S. J., & McKeehan, W. L. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-21 · Cited by 36
Novel Mediators of Adipose Tissue and Muscle Crosstalk
Indrakusuma, I., Sell, H., & Eckel, J. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0174-7 · Cited by 38
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Robberecht, H. J., & Hermans, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0113 · Cited by 38
Khan, F. H., Shaw, L., Zhang, W., Gonzalez, R. M. S., Mowery, S., Oehrle, M., Zhao, X., Jenkins, T. M., Setchell, K. D. R., Inge, T. H., et al. (2016) · Obesity · doi:10.1002/oby.21658 · Cited by 37
Izaguirre, M., Gil, M. J., Monreal, I., Montecucco, F., Frühbeck, G., & Catalán, V. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0866-3 · Cited by 41
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 37
Metformin Therapy Aggravates Neurodegenerative Processes in ApoE –/– Mice
Kuhla, A., Brichmann, E., Rühlmann, C., Thiele, R., Meuth, L., & Vollmar, B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181017 · Cited by 37
Morita, M., Siddiqui, N., Katsumura, S., Rouya, C., Larsson, O. S., Nagashima, T., Hekmatnejad, B., Takahashi, A., Kiyonari, H., Zang, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816023116 · Cited by 37
Kim, C.-S., Joe, Y., Choi, H., Back, S. H., Park, J. W., Chung, H., Roh, E., Kim, M., Ha, T. Y., & Yu, R. (2019) · Journal of Inflammation · doi:10.1186/s12950-019-0221-3 · Cited by 36
Ritchie, M. M., Hanouneh, I. A., Noureddin, M., Rolph, T., & Alkhouri, N. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1718104 · Cited by 37
Preliminary Study of Serum Biomarkers Associated With Delirium After Major Cardiac Surgery
McKay, T. B., Rhee, J., Colon, K. M., Adelsberger, K., Turco, I., Mueller, A., Qu, J. Z., & Akeju, O. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.05.002 · Cited by 34
A comparative study of metformin and nicotinamide riboside in alleviating tissue aging in rats
Geng, L., Zhang, B., Liu, H., Wang, S., Cai, Y., Yang, K., Zou, Z., Jiang, X., Liu, Z., Li, W., et al. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac045 · Cited by 37
Cardioprotective mechanisms activated in response to myocardial ischemia.
Liu, S. Q., Tefft, B. J., Zhang, D., Roberts, D., Schuster, D. J., & Wu, A. (2011) · PubMed · Cited by 36
Hypoxia and low‐nutrition double stress induces aggressiveness in a murine model of melanoma
Osawa, T., Muramatsu, M., Watanabe, M., & Shibuya, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01105.x · Cited by 37
Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model
Shao, M., Yu, L., Zhang, F., Lu, X., Li, X., Cheng, P., Lin, X., He, L., Jin, S., Tan, Y., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00026.2015 · Cited by 37
Acute effect of exercise intensity on circulating FGF-21, FSTL-1, cathepsin B, and BDNF in young men
Ji, M., Cho, C., & Lee, S. (2023) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2023.11.002 · Cited by 36
Das, S., Mukhuty, A., Mullen, G. P., & Rudolph, M. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126681 · Cited by 43
Villarroya, F., & Giralt, M. (2015) · Endocrinology · doi:10.1210/en.2015-1423 · Cited by 38
Heilbronn, L. K., Campbell, L. V., Xu, A., & Samocha‐Bonet, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078864 · Cited by 36
Johnson, C. L., Mehmood, R., Laing, S. W., Stepniak, C. V., Kharitonenkov, A., & Pin, C. L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00559.2013 · Cited by 36
Transcriptional Regulation of Fibroblast Growth Factor 21 Expression
Bae, K.-H., Kim, J., & Park, K. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.2.105 · Cited by 37
Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state
Guan, D., Zhao, L., Chen, D., Yu, B., & Yu, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0821-0 · Cited by 36
A High Phosphorus Diet Affects Lipid Metabolism in Rat Liver: A DNA Microarray Analysis
Chun, S., Bamba, T., Suyama, T., Ishijima, T., Fukusaki, E., Abe, K., & Nakai, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155386 · Cited by 38
Tamucci, K. A., Namwanje, M., Fan, L., & Qiang, L. (2017) · Protein & Cell · doi:10.1007/s13238-017-0434-2 · Cited by 39
FGF-21 Elevated IL-10 Production to Correct LPS-Induced Inflammation
Li, J., Wang, N., Khoso, M. H., Shen, C.-B., Guo, M.-Z., Pang, X.-X., Li, D., & Wang, W. (2018) · Inflammation · doi:10.1007/s10753-018-0729-3 · Cited by 36
Liu, J., Cai, G., Li, M., Fan, S., Yao, B., Ping, W., Huang, Z., Cai, H., Dai, Y.-Y., Wang, L., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.004 · Cited by 36
Ong, K. L., Hui, N., Januszewski, A. S., Kaakoush, N. O., Xu, A., Fayyad, R. S., DeMicco, D. A., Jenkins, A. J., KEECH, A. C., Waters, D. D., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.11.006 · Cited by 38
Emerging Structure–Function Paradigm of Endocrine FGFs in Metabolic Diseases
Luo, Y., Ye, S., Li, X., & Lu, W. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.002 · Cited by 37
Therapeutic Approaches to Alzheimer’s Type of Dementia: A Focus on FGF21 Mediated Neuroprotection
Taliyan, R., Chandran, S. K., & Kakoty, V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716101411 · Cited by 35
Cooke, D., Mattocks, D. A. L., Nichenametla, S. N., Anunciado‐Koza, R. P., Koza, R. A., & Ables, G. P. (2020) · Obesity · doi:10.1002/oby.22763 · Cited by 36
Hepatic rRNA Transcription Regulates High-Fat-Diet-Induced Obesity
Oie, S., Matsuzaki, K., Yokoyama, W., Tokunaga, S., Waku, T., Han, S., Iwasaki, N., Mikogai, A., Yasuzawa-Tanaka, K., Kishimoto, H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.038 · Cited by 39
Koh, K. H., Pan, X., Zhang, W., McLachlan, A., Urrutia, R. A., & Jeong, H. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093666 · Cited by 36
Metadata
- Authors
- Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., Gromada, J., Brozinick, J. T., Hawkins, E. D., Wroblewski, V. J., Li, D.-S., Mehrbod, F., Jaskunas, S. R., & Shanafelt, A. B.
- Affiliations
- Eli Lilly (United States) (US)
- Corresponding author
- Kharitonenkov, Alexei
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2005-06-01
- Volume
- 115
- Issue
- 6
- Pages
- 1627-1635
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1088017
- OpenAlex
- W2000665430
- Cited by
- 2,125
- References
- 46
- Citations by year
- 2026: 72 · 2025: 99 · 2024: 111 · 2023: 120 · 2022: 137 · 2021: 138 · 2020: 116 · 2019: 136 · 2018: 147 · 2017: 135 · 2016: 142 · 2015: 155 · 2014: 124 · 2013: 125 · 2012: 115
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Hospital for Sick Children
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- FGF21, diabetes mellitus, glucose uptake, adipocytes, diet-induced obesity, transgenic mice, ob/ob mice, db/db mice, plasma glucose, triglycerides, metabolic regulation, diabetes treatment
- MeSH terms
- Animals, Blood Glucose, Cell Division, Cells, Cultured, Diabetes Mellitus, Fibroblast Growth Factors, Humans, Hyperglycemia, Hypoglycemic Agents, Mice, Obese, Mice, Transgenic, Triglycerides, Weight Gain, Adipocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
